From: Virologic failure and metabolic syndrome in patients with HIV infection
 | SM+ | SM- | p |
---|---|---|---|
Systolic BP, mmHg | 129.84 ± 14.43 | 117.72 ± 14.67 | < 0.0001 |
Diastolic BP, mmHg | 86.88 ± 11.01 | 76.43 ± 12.42 | < 0.0001 |
Glucose, mg/dL | 107.73 ± 34.57 | 91.74 ± 13.84 | < 0.0001 |
HDL, mg/dL | 35.85 ± 8.63 | 48.84 ± 16.08 | < 0.0001 |
Triglycerides, mg/dL | 300.91 ± 206.15 | 179.15 ± 159.54 | < 0.0001 |
Apo B, mg/dL | 111.51 ± 29.64 | 100.57 ± 31.22 | < 0.0001 |
TCol/HDL | 5.58 ± 1.63 | 4.21 ± 1.46 | < 0.0001 |
HOMA > 3.8, n (%) | 210 (65.02) | 354 (35.36) | < 0.0001 |
HOMA, median (IQR) | 5.14 (3.00; 8.15) | 2.95 (1.93; 4.57) | < 0.0001 |
HIV duration, months | 169.33 ± 62.15 | 172.35 ± 64.46 | 0.46 |
Log10 VL | 2.17 ± 0.94 | 2.02 ± 0.79 | 0.0048 |
CD4 nadir, median (IQR) | 150 (50; 250) | 146 (60; 238) | 0.86 |
CD4 current, median (IQR) | 500 (342; 701) | 502 (357; 681) | 0.99 |
BMI | 25.17 ± 4.40 | 22.80 ± 3.38 | < 0.0001 |
Waist, cm | 91.04 ± 11.27 | 83.71 ± 9.41 | < 0.0001 |
PI current | 199 (61.61) | 529 (52.85) | 0.006 |
NRTI current | 321 (99.38) | 998 (98.70) | 0.31 |
NNRTI current | 90 (27.86) | 381 (38.06) | 0.001 |
PI exposure, months | 51.37 ± 47.95 | 49.05 ± 43.57 | 0.41 |
NRTI exposure, months | 104.08 ± 58.67 | 108.46 ± 56.17 | 0.23 |
NNRTI exposure, months | 26.15 ± 26.78 | 30.18 ± 30.94 | 0.0358 |
HCV | 102 (31.58) | 372 (37.16) | 0.17 |
VAT/TAT | 0.54 ± 0.17 | 0.48 ± 0.18 | < 0.0001 |
%fat leg, median (IQR) | 8.97 (5.89; 15.79) | 9.67 (5.86; 15.88) | 0.61 |
%fat leg/BMI, median (IQR) | 0.36 (0.25; 0.61) | 0.41 (0.26; 0.70) | 0.0074 |
Trunk fat, g | 7343.25 ± 3720.89 | 5943.93 ± 3219.04 | < 0.0001 |
Total fat, g | 12451.16 ± 7293.54 | 10200.50 ± 5768.74 | < 0.0001 |
Total lean, g | 53038.16 ± 9722.90 | 48689.95 ± 10030.84 | < 0.0001 |